Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.


The Atlantic
Accessed 10 Apr 2021
What America’s Vaccination Campaign Proves to the World
The U.S. stumbled early in the pandemic, but the vaccine rollout could reboot the country’s image.
Apr 10. 2021
Anne Applebaum, Staff writer at The Atlantic

Vaccine Refusal Will Come at a Cost—For All of Us
People who refuse to get the COVID-19 vaccine will have higher health-care costs. The rest of us will foot the bill.
Edward-Isaac Dovere
Apr 10. 2021

A Better Solution Than Laminating Your Vaccine Card
Political grandstanding about vaccine passports serves no one.
James Hamblin
April 9, 2021


Accessed 10 Apr 2021
[No new, unique, relevant content]


The Economist
Accessed 10 Apr 2021
The Americas
Cuba may become the smallest country to make covid-19 vaccines …
Whether they will be approved elsewhere remains to be seen
Apr 10th 2021 edition


Financial Times
Accessed 10 Apr 2021
Coronavirus: Georgia pauses J&J vaccine at one site following adverse reactions — as it happened
India rejects vaccine shortage claims
April 9, 2021


Accessed 10 Apr 2021
[No new, unique, relevant content]


Foreign Affairs
Accessed 10 Apr 2021
Snapshot April 5, 2021
The New Age of Protectionism
Wealthy democratic governments have pushed liberal market principles aside in the face of vaccine shortages.
Henry Farrell and Abraham Newman


Foreign Policy
Accessed 10 Apr 2021
China Brief
China’s Vaccine Diplomacy Has Mixed Results
Concerns about the efficacy of Sinovac and Sinopharm has dented their reputation, even among allies of Beijing.
By James Palmer
| April 7, 2021, 5:59 PM


New Yorker
Accessed 10 Apr 2021
[No new, unique, relevant content]


New York Times
Accessed 10 Apr 2021
Incarcerated and Infected: How the Virus Tore Through the U.S. Prison System
Since March 2020, New York Times reporters have tracked every known coronavirus case in every correctional setting in the nation. More than 2,700 inmates have died.
By Eddie Burkhalter, Izzy Colón, Brendon Derr, Lazaro Gamio, Rebecca Griesbach, Ann Hinga Klein, Danya Issawi, K.b. Mensah, Derek M. Norman, Savannah Redl, Chloe Reynolds, Emily Schwing, Libby Seline, Rachel Sherman, Maura Turcotte and Timothy Williams
April 10

Asia Pacific
Complacency and Missteps Deepen a Covid-19 Crisis in India
The new wave will hurt global efforts and vaccine supplies, experts say. Researchers are scrambling to assess whether new coronavirus variants are playing a role in India.
By Mujib Mashal and Hari Kumar
April 9

I.M.F. Seminar Stresses Importance of Global Vaccinations
Jerome H. Powell, the Federal Reserve chair, and the managing director of the International Monetary Fund, Kristalina Georgieva, emphasized the economic need for worldwide vaccinations on Thursday.
By Reuters
April 9


Washington Post
Accessed 10 Apr 2021
J&J vaccine problems hamper US military vaccines overseas
WASHINGTON — U.S. military leaders said Thursday that recent problems with the Johnson & Johnson vaccine have made it more difficult to provide shots for forces overseas, and that vaccines have been offered to service members’ families or other tier two beneficiaries in only 40% of the military sites outside the U.S.
Apr 8, 2021